287 related articles for article (PubMed ID: 2983809)
21. The administration of baclofen to mice increases 5-HT2-mediated head-twitch behaviour and 5-HT2 receptor number in frontal cortex.
Metz A; Goodwin GM; Green AR
Neuropharmacology; 1985 Apr; 24(4):357-60. PubMed ID: 4000408
[TBL] [Abstract][Full Text] [Related]
22. Further evidence for a relationship between changes in GABA concentration in rat brain and enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shock.
Green AR; Sant K; Bowdler JM; Cowen PJ
Neuropharmacology; 1982 Oct; 21(10):981-4. PubMed ID: 7145036
[TBL] [Abstract][Full Text] [Related]
23. Hypothermia induced by baclofen, a possible index of GABAB receptor function in mice, is enhanced by antidepressant drugs and ECS.
Gray JA; Goodwin GM; Heal DJ; Green AR
Br J Pharmacol; 1987 Dec; 92(4):863-70. PubMed ID: 2827829
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of chronic antidepressants in behavioural tests of beta-adrenergic and GABAB receptor function.
McManus DJ; Greenshaw AJ
Psychopharmacology (Berl); 1991; 103(2):204-8. PubMed ID: 1851308
[TBL] [Abstract][Full Text] [Related]
25. Lithium decreases 5-HT1A and 5-HT2 receptor and alpha 2-adrenoceptor mediated function in mice.
Goodwin GM; DeSouza RJ; Wood AJ; Green AR
Psychopharmacology (Berl); 1986; 90(4):482-7. PubMed ID: 3027734
[TBL] [Abstract][Full Text] [Related]
26. Phenylephrine-induced activity in mice as a model of central alpha 1-adrenoceptor function. Effects of acute and repeated administration of antidepressant drugs and electroconvulsive shock.
Heal DJ
Neuropharmacology; 1984 Nov; 23(11):1241-51. PubMed ID: 6152017
[TBL] [Abstract][Full Text] [Related]
27. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
[TBL] [Abstract][Full Text] [Related]
28. Increased 5-HT2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats.
Green AR; Johnson P; Nimgaonkar VL
Br J Pharmacol; 1983 Sep; 80(1):173-7. PubMed ID: 6228277
[TBL] [Abstract][Full Text] [Related]
29. MK-801 prevents the enhanced behavioural response to apomorphine elicited by repeated electroconvulsive treatment in mice.
Nomikos GG; Mathé AA; Mathé JM; Svensson TH
Psychopharmacology (Berl); 1992; 108(3):367-70. PubMed ID: 1387964
[TBL] [Abstract][Full Text] [Related]
30. Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock.
Luchowska E; Luchowski P; Wielosz M; Kleinrok Z; Czuczwar SJ; Urbańska EM
Pharmacol Biochem Behav; 2002; 71(1-2):223-31. PubMed ID: 11812526
[TBL] [Abstract][Full Text] [Related]
31. Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour.
Green AR; Deakin JF
Nature; 1980 May; 285(5762):232-3. PubMed ID: 7374776
[TBL] [Abstract][Full Text] [Related]
32. Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodents.
Heal DJ; Akagi H; Bowdler JM; Green AR
Eur J Pharmacol; 1981 Nov; 75(4):231-7. PubMed ID: 7318908
[TBL] [Abstract][Full Text] [Related]
33. Sex-related differences in central adrenergic function and responsiveness to repeated administration of desipramine or electroconvulsive shock.
Heal DJ; Bristow LM; Hurst EM; Elliott JM; Buckett WR
Br J Pharmacol; 1989 May; 97(1):111-8. PubMed ID: 2541853
[TBL] [Abstract][Full Text] [Related]
34. Progabide, a GABA mimetic drug, stimulates the secretion of plasma corticosterone in rats.
Manev H; Pericić D
Pharmacol Biochem Behav; 1987 Dec; 28(4):443-6. PubMed ID: 3432311
[TBL] [Abstract][Full Text] [Related]
35. Chronic antidepressant treatment reduces central beta-adrenoceptor sensitivity in a behavioural test.
Handley SL; Singh L
Eur J Pharmacol; 1986 Aug; 127(1-2):97-103. PubMed ID: 3019728
[TBL] [Abstract][Full Text] [Related]
36. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in the mouse cortex has pharmacological characteristics compatible with mediation via 5-HT2 receptors but this response does not reflect altered 5-HT2 function after 5,7-dihydroxytryptamine lesioning or repeated antidepressant treatments.
Godfrey PP; McClue SJ; Young MM; Heal DJ
J Neurochem; 1988 Mar; 50(3):730-8. PubMed ID: 2828545
[TBL] [Abstract][Full Text] [Related]
37. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
De Souza RJ; Goodwin GM; Green AR; Heal DJ
Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
[TBL] [Abstract][Full Text] [Related]
38. Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Cioczek JD; Kocharov SL; Andres-Mach M; Kominek M; Zolkowska D
Eur J Pharmacol; 2010 Dec; 648(1-3):74-9. PubMed ID: 20826140
[TBL] [Abstract][Full Text] [Related]
39. Experimental basis for the antidepressant action of the GABA receptor agonist progabide.
Bartholini G
Neurosci Lett; 1984 Jun; 47(3):351-5. PubMed ID: 6089056
[TBL] [Abstract][Full Text] [Related]
40. Effects of electroconvulsive shock on monoaminergic systems in the rat brain. Thesis.
Wielosz M
Pol J Pharmacol Pharm; 1983; 35(2):127-30. PubMed ID: 6684770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
